Liver transplantation for primary or secondary endocrine tumors.
Endocrine tumors comprise a heterogeneous group of rare neoplasms. Liver metastatic endocrine tumors (MET) are amenable to various therapeutic modalities including liver transplantation (LT). However, LT for MET remains controversial because of the lack of clear selection criteria. The purpose of this study based on thorough perusal of English and French literature since 1989 was to identify prognostic factors and propose recommendations for selecting patients most likely to benefit LT for primary and secondary endocrine tumors.
Gregoire
Emilie
E
Department of Digestive Surgery and Liver Transplantation, Hôpital de La Conception, and Université de la Mediterranée, Marseille, France.
Le Treut
Yves Patrice
YP
D006528:Carcinoma, Hepatocellular / Q000601:surgery; D004701:Endocrine Gland Neoplasms / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D016031:Liver Transplantation / Q000401:mortality; D009382:Neoplasms, Unknown Primary; D018358:Neuroendocrine Tumors / Q000556:secondary / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000601:surgery; D018579:Patient Selection; D011379:Prognosis
D019394:Ki-67 Antigen